|
Bladder Cancer Diagnosis & Monitoring Center - Media Resources |
|
|
|
|
|
|
|
|
|
Bladder Cancer Diagnosis and Monitoring Center
Media Resources
Podcast - "Ask the Expert" - We Tried NMP22 Five Years Ago when it First Came Out and after Receiving False Negatives, We Elected to not Continue its Use. Do you have Confidence in the Sensitivity of the Test?
Thursday, 17 July 2008
Podcast - "Ask the Expert" - I am Getting a Positive NMP22 result but a Negative Cystoscopy. What does it Mean?
Thursday, 17 July 200
Podcast - "Ask the Expert" - Do You have an Opinion as to when the NMP22 Test Should be Run?
Thursday, 17 July 2008
Podcast - "Ask the Expert" - Should the NMP22 Test be Taken Prior to Cystoscopy or at the Same Patient Visit?
Thursday, 17 July 2008
Podcast - San Francisco Firefighters and Bladder Cancer Screening
Tuesday, 19 June 2007
Podcast - Updates on Bladder Cancer and San Francisco Firefighters
Tuesday, 19 June 2007
Podcast - AUA 2007 - Impact Risk Factors on the Performance of a Point-of-Care Bladder Cancer Test
Tuesday, 22 May 2007
Podcast - AUA 2007 - Evaluation and Workup of Hematuria among Primary Care Physicians in Miami-Dade County: An Anonymous Questionnaire-based Survey
Tuesday, 22 May 2007
Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay
By Giora Katz, MD & Raoul Salup, MD and the NMP22 Clinical Investigation Group
Improving the Diagnosis of Bladder Cancer
By Mark S. Soloway MD - Combining Cystoscopy with a Physician's Office Tumor Marker Test - CME Training Program
Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using aPoint-of-Care Proteomic Assay
By Barry Stein, MD, Giora Katz, MD and the NMP22 Clinical Investigation Group
Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
By Yair Lotan MD
Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
By Giora Katz, MD
Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
By Giora Katz, MD
Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
By H. Barton Grossman, M.D. and the NMP22 Clinical Investigation Group
Bladder Cancer Awareness Week
November 2006
Please log-in or register in order to submit comments. Powered by AkoComment! |